代谢综合征对机器人肝切除术围手术期结局的影响:倾向性评分匹配分析
本研究前瞻性随访2016至2020年接受机器人肝切除术的272例患者,其中39例(14%)合并代谢综合征,经1:1倾向性评分匹配后纳入74例(每组37例)。匹配后代谢综合征组仅BMI显著更高,两组术中指标及所有术后结局指标均无统计学差异,提示代谢综合征对机器人肝切除术的围手术期结局无显著影响。
要点
- 代谢综合征患者接受机器人肝切除术后术中指标及术后结局与无代谢综合征者无显著差异。
- 匹配后代谢综合征组BMI显著更高(34±5.7 vs. 26±4.4 kg/m2,p<0.001)。
- 机器人入路可能减轻代谢综合征对肝切除术患者的不良影响。
核心结论
- 代谢综合征对机器人肝切除术的术中指标、术后指标、并发症及结局均无影响。
- 研究者认为机器人入路可能减轻代谢综合征对肝切除术患者的不良影响。
研究设计与样本
- 前瞻性随访2016至2020年接受机器人肝切除术的患者,共272例。
- 采用1:1倾向性评分匹配(PSM)分析合并与不合并代谢综合征的患者,匹配后共74例,每组37例,其中28%有肝硬化。
- 代谢综合征定义为BMI≥28.8 kg/m2、糖尿病和高血压。
主要发现
- 272例中39例(14%)有代谢综合征。
- 匹配前,代谢综合征组BMI更高(34±5.6 vs. 28±5.9 kg/m2,p<0.001)、MELD评分更高(10±4.5 vs. 8±3.2,p<0.001)、肝硬化发生率更高(33% vs. 9%,p=0.0002)。
- 匹配后,BMI(34±5.7 vs. 26±4.4 kg/m2,p<0.001)是唯一与代谢综合征相关的术前变量。
- 匹配前后,两组在手术时间、出血量、中转开腹及术中并发症等术中指标上均无统计学差异。
- 匹配前后,所有术后结局指标与是否合并代谢综合征均无相关性。
临床怎么用
- 代谢综合征不应被视为机器人肝切除术的禁忌证。
- 对合并代谢综合征的患者,机器人肝切除术的围手术期结局与无代谢综合征者相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Metabolic syndrome is a known risk factor for postoperative complications after general surgical procedures. Literature analyzing perioperative outcomes of patients with metabolic syndrome undergoing a minimally invasive hepatectomy is limited. We sought to investigate if metabolic syndrome significantly impacts the perioperative course and outcomes of patients undergoing robotic hepatectomy. METHODS: With IRB, we prospectively followed patients who underwent robotic hepatectomy from 2016 through 2020. A 1:1 propensity score-matched (PSM) analysis was applied to patients with and without metabolic syndrome. Demographic and clinical data were analyzed for those cohorts before and after PSM. Metabolic syndrome was defined as BMI ≥ 28.8 kg/m2, diabetes, and hypertension. RESULTS: A total of 272 patients underwent robotic hepatectomy, 39 (14%) of whom had metabolic syndrome. After performing PSM, we ended up with 74 patients, 37 in each cohort, 28% of them had liver cirrhosis. Patients with metabolic syndrome had higher BMI (34 ± 5.6 vs. 28 ± 5.9 kg/m2, p < 0.001) and MELD scores (10 ± 4.5 vs. 8 ± 3.2, p < 0.001) compared to patients without metabolic syndrome. Additionally, patients with metabolic syndrome had an increased incidence of liver cirrhosis (33% vs. 9%, p = 0.0002). Following PSM, BMI (34 ± 5.7 vs. 26 ± 4.4 kg/m2, p < 0.001) was the only preoperative variables associated with metabolic syndrome. There were no statistical differences before and after PSM between patients with and without metabolic syndrome in terms of intraoperative metrics including operative time, blood loss, conversion to 'open,' and intraoperative complications. All postoperative outcomes metrics before and after PSM did not correlate with the presence or absence of metabolic syndrome. CONCLUSIONS: Metabolic syndrome had no impact on intra- or postoperative metrics, complications, or outcomes after robotic hepatectomy. We believe that the robotic approach may mitigate the adverse effects of metabolic syndrome for patients undergoing robotic hepatectomy.
引用
- Jacoby H, Sucandy I, Ross S, et al. Does metabolic syndrome affect perioperative outcomes in patients undergoing robotic hepatectomy? A propensity score-matched analysis. Surg Endosc. 2023. PMID: 37038021. doi:10.1007/s00464-023-10047-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。